Data is not available at this time.
Koken Ltd. operates in the healthcare sector, specializing in occupational personal protective equipment and environmental quality improvement solutions. The company’s diversified portfolio includes clean air systems, antibacterial agents, respirators, and protective gear, catering to both industrial and consumer markets. Its Mask-Related Business and Environmental-Related Businesses segments highlight a focus on hygiene and safety, positioning Koken as a key player in Japan’s medical devices industry. The company leverages its long-standing expertise, established in 1943, to maintain a strong market presence, particularly in disaster preparedness and contamination control. Its innovative products, such as the KOACH clean zone creator and IMADEZE antibacterial agent, demonstrate a commitment to technological advancement and regulatory compliance. Koken’s dual focus on industrial and consumer applications provides resilience against market fluctuations, though competition in the protective equipment space remains intense.
Koken reported revenue of JPY 10.76 billion for the period, with net income of JPY 722 million, reflecting a modest but stable profitability margin. Operating cash flow stood at JPY 666 million, indicating efficient working capital management. Capital expenditures of JPY -221 million suggest disciplined investment in growth initiatives, though the company maintains a conservative approach to expansion.
The company’s diluted EPS of JPY 146.04 underscores its ability to generate earnings per share effectively. With a market capitalization of JPY 8.25 billion, Koken’s capital efficiency is balanced, supported by its niche focus in protective equipment. The low beta of 0.094 indicates minimal correlation with broader market volatility, reflecting its defensive positioning.
Koken’s balance sheet shows JPY 2.53 billion in cash and equivalents against total debt of JPY 5.18 billion, suggesting moderate leverage. The company’s liquidity position appears manageable, though debt levels warrant monitoring. Its asset-light model, evidenced by controlled capital expenditures, supports financial stability.
Growth trends remain steady, driven by demand for safety and hygiene products. The dividend per share of JPY 35 reflects a shareholder-friendly policy, though payout ratios are conservative. Future growth may hinge on expanding its product line and geographic reach beyond Japan.
With a market cap of JPY 8.25 billion, Koken trades at a valuation reflective of its niche market role. Investors likely price in stable demand for its products, though limited international exposure may cap upside potential. The low beta suggests it is viewed as a defensive holding.
Koken’s strategic advantages lie in its specialized product offerings and entrenched market position. The outlook remains stable, supported by regulatory tailwinds in workplace safety. However, diversification into new markets or technologies could enhance long-term growth prospects.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |